128 results  1 of 7 

1 MST1R as a potential new target antigen of chimeric antigen receptor T cells to treat solid tumors
Wen An, Ju-Seop Kang, Sukjoong Oh, Ang Tu
Korean J Physiol Pharmacol.2023;27(3):241-256.   Published online 2023 May 1     DOI: http://dx.doi.org/10.4196/kjpp.2023.27.3.241
      
2 Comparison of the prevalence and histology between primary benign bladder tumors and recurrent benign lesions after transurethral resection of malignant bladder tumors
Jae Jin Baek, Yong Deuk Seo, Dong Ha Kim, Won Tae Seo, Su Hwan Kang, Taek Sang Kim, Bong Kwon Chun
Kosin Med J.2023;38(1):43-49.   Published online 2023 February 17     DOI: http://dx.doi.org/10.7180/kmj.22.133
      
3 The proteomic landscape shows oncologic relevance in cystitis glandularis
Jun Yong Kim, Dohyun Han, Hyeyoon Kim, Minsun Jung, Han Suk Ryu
J Pathol Transl Med.2023;57(1):67-74.   Published online 2022 December 22     DOI: http://dx.doi.org/10.4132/jptm.2022.10.24
      
4 Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
Hongsik Kim, Byong Chang Jeong, Joohyun Hong, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Wan Song, Hyun Hwan Sung, Jung Yong Hong, Se Hoon Park
Cancer Res Treat.2023;55(2):636-642.   Published online 2022 October 6     DOI: http://dx.doi.org/10.4143/crt.2022.343
      
5 Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy
Ryul Kim, Jung Yong Hong, Jeeyun Lee, Ghee Young Kwon, Byong Chang Jeong, Se Hoon Park
Cancer Res Treat.2022;54(3):894-906.   Published online 2021 November 17     DOI: http://dx.doi.org/10.4143/crt.2021.854
      
6 Next-Generation Proteomics–Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis
Jungyo Suh, Dohyun Han, Ja Hyeon Ku, Hyeon Hoe Kim, Cheol Kwak, Chang Wook Jeong
Cancer Res Treat.2022;54(3):882-893.   Published online 2021 October 9     DOI: http://dx.doi.org/10.4143/crt.2021.642
      
7 The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
Hyehyun Jeong, Kye Jin Park, Yongjune Lee, Hyung-Don Kim, Jwa Hoon Kim, Shinkyo Yoon, Bumsik Hong, Jae Lyun Lee
Cancer Res Treat.2022;54(1):226-233.   Published online 2021 May 6     DOI: http://dx.doi.org/10.4143/crt.2021.365
      
8 The effect of atropine in preventing catheter-related pain and discomfort in patients undergoing transurethral resection due to bladder tumor; prospective randomized, controlled study
Yeliz Şahiner, Yeliz Şahiner, Arzu Akdağlı Ekici, Musa Ekici, Emre Demir
Korean J Pain.2020;33(2):176-182.   Published online 2020 April 1     DOI: http://dx.doi.org/10.3344/kjp.2020.33.2.176
      
9 Seminal Vesicle Involvement by Carcinoma In Situ of the Bladder: Clonal Analysis Using Next-Generation Sequencing to Elucidate the Mechanism of Tumor Spread
Hyun Sik Park, Hyun Bin Shin, Myung-Shin Lee, Joo Heon Kim, Seon-Young Kim, Jinsung Park
Cancer Res Treat.2020;52(4):1283-1287.   Published online 2020 March 19     DOI: http://dx.doi.org/10.4143/crt.2020.002
      
10 Advances in urinary biomarker discovery in urological research
Jayoung Kim, Won Tae Kim, Wun-Jae Kim
Investig Clin Urol.2020;61(Suppl 1):S8-S22.   Published online 2019 December 31     DOI: http://dx.doi.org/10.4111/icu.2020.61.S1.S8
      
11 Do patients benefit from total intracorporeal robotic radical cystectomy?: A comparative analysis with extracorporeal robotic radical cystectomy from a Korean multicenter study
Ji Sung Shim, Tae Gyun Kwon, Koon Ho Rha, Young Goo Lee, Ji Youl Lee, Byong Chang Jeong, Jong Hyun Pyun, Sung Gu Kang, Seok Ho Kang
Investig Clin Urol.2020;61(1):11-18.   Published online 2019 December 18     DOI: http://dx.doi.org/10.4111/icu.2020.61.1.11
      
12 Oncological and functional outcomes of robot-assisted radical cystectomy in bladder cancer patients in a single tertiary center: Can these be preserved throughout the learning curve?
Jong Hyun Tae, Jong Hyun Pyun, Ji Sung Shim, Seok Cho, Sung Gu Kang, Young Hwii Ko, Jun Cheon, Jeong Gu Lee, Seok Ho Kang
Investig Clin Urol.2019;60(6):463-471.   Published online 2019 October 7     DOI: http://dx.doi.org/10.4111/icu.2019.60.6.463
      
13 Improving the diagnosis of high grade and stage bladder cancer by detecting increased urinary calprotectin expression in tumor tissue and tumor-associated inflammatory response
Yusuf Sahin, Ugur Yucetas, Huseyin Aytaç Ates, Erkan Erkan, Esma Yucetas, Mustafa Zafer Temiz, Mahmut Gokhan Toktas, Mustafa Kadihasanoglu, Birsen Cigdem Topkaya
Investig Clin Urol.2019;60(5):343-350.   Published online 2019 August 19     DOI: http://dx.doi.org/10.4111/icu.2019.60.5.343
      
14 Suppression of CD81 promotes bladder cancer cell invasion through increased matrix metalloproteinase expression via extracellular signal-regulated kinase phosphorylation
Hyun Sik Park, Suhyuk Lee, Jisu Lee, Hyun Bin Shin, Seung-Min Yoo, Myung-Shin Lee, Jinsung Park
Investig Clin Urol.2019;60(5):396-404.   Published online 2019 July 17     DOI: http://dx.doi.org/10.4111/icu.2019.60.5.396
      
15 Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials
Do Kyung Kim, Joo Yong Lee, Jae Hung Jung, Yoon Soo Hah, Kang Su Cho
Investig Clin Urol.2019;60(2):64-74.   Published online 2019 January 31     DOI: http://dx.doi.org/10.4111/icu.2019.60.2.64
      
16 Oncologic, Perioperative Outcomes of Female Radical Cystectomy: Results from a Multicenter Study in Korea
Ji Sung Shim, Ho Kyung Seo, Ja Hyeon Ku, Byong Chang Jeong, Bumsik Hong, Seok Ho Kang
Cancer Res Treat.2019;51(3):1064-1072.   Published online 2018 October 30     DOI: http://dx.doi.org/10.4143/crt.2018.515
      
17 Immune checkpoint inhibitors for urothelial carcinoma
Hyung Suk Kim, Ho Kyung Seo
Investig Clin Urol.2018;59(5):285-296.   Published online 2018 August 31     DOI: http://dx.doi.org/10.4111/icu.2018.59.5.285
      
18 Can tumor recurrence be reduced with plasma-kinetic vaporization of the area around the tumor in nonmuscle invasive bladder cancer?
Yüksel Yılmaz, Mehmet Cemal Kahya, Fatma Hüsniye Dilek, Osman Köse, Serkan Özcan, Ertan Can, Yiğit Akın, Batuhan Ergani, Ahmet Selçuk Dindar
Investig Clin Urol.2018;59(4):223-231.   Published online 2018 June 27     DOI: http://dx.doi.org/10.4111/icu.2018.59.4.223
      
19 Health-Related Quality of Life, Perceived Social Support, and Depression in Disease-Free Survivors Who Underwent Curative Surgery Only for Prostate, Kidney and Bladder Cancer: Comparison among Survivors and with the General Population
Dong Wook Shin, Hyun Sik Park, Sang Hyub Lee, Seung Hyun Jeon, Seok Cho, Seok Ho Kang, Seung Chol Park, Jong Hyock Park, Jinsung Park
Cancer Res Treat.2019;51(1):289-299.   Published online 2018 May 4     DOI: http://dx.doi.org/10.4143/crt.2018.053
      
20 What do patients with urothelial cancer know about the association of their tumor disease with smoking habits? Results of a German survey study
Matthias May, Hans-Martin Fritsche, Christian Gilfrich, Mirja Dombrowski, Odilo Maurer, Philipp Spachmann, Manju Ganesh Kumar, Marc Bjurlin, Maximilian Burger, Sabine Brookman-May
Investig Clin Urol.2018;59(2):91-97.   Published online 2018 February 28     DOI: http://dx.doi.org/10.4111/icu.2018.59.2.91
      

 1 of 7